199 related articles for article (PubMed ID: 32079232)
1. Antibacterial Activity and Pharmacokinetic Profile of a Promising Antibacterial Agent: 22-(2-Amino-phenylsulfanyl)-22-Deoxypleuromutilin.
Zuo X; Fang X; Zhang Z; Jin Z; Xi G; Liu Y; Tang Y
Molecules; 2020 Feb; 25(4):. PubMed ID: 32079232
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and biological evaluation of novel pleuromutilin derivatives possessing acetamine phenyl linker.
Jin Z; Wang L; Gao H; Zhou YH; Liu YH; Tang YZ
Eur J Med Chem; 2019 Nov; 181():111594. PubMed ID: 31419741
[TBL] [Abstract][Full Text] [Related]
3. Antibacterial Activity of a Promising Antibacterial Agent: 22-(4-(2-(4-Nitrophenyl-piperazin-1-yl)-acetyl)-piperazin-1-yl)-22-deoxypleuromutilin.
Zuo XY; Gao H; Gao ML; Jin Z; Tang YZ
Molecules; 2021 Jun; 26(12):. PubMed ID: 34201372
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and biological evaluation of novel pleuromutilin derivatives containing piperazine and 1,2,3-triazole linker.
Zhang GY; Zhang Z; Li K; Liu J; Li B; Jin Z; Liu YH; Tang YZ
Bioorg Chem; 2020 Dec; 105():104398. PubMed ID: 33137559
[TBL] [Abstract][Full Text] [Related]
5. In Vitro and In Vivo Antibacterial Activity, Toxicity and Resistance Analysis of Pleuromutilin Derivative Z33 against Methicillin-Resistant
Hu Y; Chen F; Zhou K; Zhang Z; Li F; Zhang J; Tang Y; Jin Z
Molecules; 2022 Aug; 27(15):. PubMed ID: 35956888
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and biological evaluation of novel pleuromutilin derivatives as potent anti-MRSA agents targeting the 50S ribosome.
Huang SY; Wang X; Shen DY; Chen F; Zhang GY; Zhang Z; Li K; Jin Z; Du D; Tang YZ
Bioorg Med Chem; 2021 May; 38():116138. PubMed ID: 33857737
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic/pharmacodynamic integration of amphenmulin: a novel pleuromutilin derivative against
Wang W; Yu J; Ji X; Xia X; Ding H
Microbiol Spectr; 2024 Feb; 12(2):e0367523. PubMed ID: 38112481
[TBL] [Abstract][Full Text] [Related]
8. Semisynthetic pleuromutilin antimicrobials with therapeutic potential against methicillin-resistant Staphylococcus aureus by targeting 50S ribosomal subunit.
Wang X; Wang R; Zhang ZS; Zhang GY; Jin Z; Shen R; Du D; Tang YZ
Eur J Med Chem; 2022 Jul; 237():114341. PubMed ID: 35430480
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and biological evaluation of pleuromutilin-Schiff base hybrids as potent anti-MRSA agents in vitro and in vivo.
Li B; Zhang Z; Zhang JF; Liu J; Zuo XY; Chen F; Zhang GY; Fang HQ; Jin Z; Tang YZ
Eur J Med Chem; 2021 Nov; 223():113624. PubMed ID: 34153574
[TBL] [Abstract][Full Text] [Related]
10. In Vitro and In Vivo Activity of 14-
Fu Y; Leng C; Fan Y; Ma X; Li X; Wang X; Guo Z; Wang X; Shang R
Molecules; 2021 May; 26(11):. PubMed ID: 34071703
[No Abstract] [Full Text] [Related]
11. Design, Synthesis, Biological Evaluation, and Molecular Docking Studies of Pleuromutilin Derivatives Containing Thiazole.
Li K; Lin C; Hu YH; Wang J; Jin Z; Zeng ZL; Tang YZ
ACS Infect Dis; 2024 Jun; 10(6):1980-1989. PubMed ID: 38703116
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and biological evaluation of novel pleuromutilin derivatives possessing 4-aminothiophenol linker as promising antibacterial agents.
Chai F; Wang J; Zhou KX; Wang SK; Liu YH; Jin Z; Tang YZ
Bioorg Chem; 2022 Sep; 126():105859. PubMed ID: 35605553
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, in vitro and in vivo evaluation against MRSA and molecular docking studies of novel pleuromutilin derivatives bearing 1, 3, 4-oxadiazole linker.
Liu J; Zhang GY; Zhang Z; Li B; Chai F; Wang Q; Zhou ZD; Xu LL; Wang SK; Jin Z; Tang YZ
Bioorg Chem; 2021 Jul; 112():104956. PubMed ID: 33991838
[TBL] [Abstract][Full Text] [Related]
14. Antibacterial activity and pharmacokinetic profile of a promising antibacterial agent: 14-O-[(4-Amino-6-hydroxy-pyrimidine-2-yl)thioacetyl] mutilin.
Shang R; Yi Y; Zhang C; Fu Y; Liang J; Pu W
Pharmacol Res; 2018 Mar; 129():424-431. PubMed ID: 29133214
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, and antibacterial activity of pleuromutilin derivatives.
Liu HX; Yao WY; Cui G; Zhou J; Yan H; Guo H; Wang YW; Zhang Y
Chem Biol Drug Des; 2024 Jun; 103(6):e14554. PubMed ID: 38806405
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and biological activities of novel pleuromutilin derivatives with a substituted triazole moiety as potent antibacterial agents.
Zhang Z; Li K; Zhang GY; Tang YZ; Jin Z
Eur J Med Chem; 2020 Oct; 204():112604. PubMed ID: 32731187
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, biological evaluation and molecular docking studies of novel pleuromutilin derivatives containing nitrogen heterocycle and alkylamine groups.
Wang Q; Liu J; Zhou ZD; Zhou KX; Li F; Zhang QW; Wang SK; Wang W; Jin Z; Tang YZ
J Enzyme Inhib Med Chem; 2022 Dec; 37(1):2078-2091. PubMed ID: 35875944
[TBL] [Abstract][Full Text] [Related]
18. Design, Synthesis and Biological Evaluation of Novel Pleuromutilin Derivatives Containing 6-Chloro-1-R-1
Wang J; Hu YH; Zhou KX; Wang W; Li F; Li K; Zhang GY; Tang YZ
Molecules; 2023 May; 28(9):. PubMed ID: 37175382
[TBL] [Abstract][Full Text] [Related]
19. Novel pleuromutilin derivatives with excellent antibacterial activity against Staphylococcus aureus.
Xu P; Zhang YY; Sun YX; Liu JH; Yang B; Wang YZ; Wang YL
Chem Biol Drug Des; 2009 Jun; 73(6):655-60. PubMed ID: 19635057
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, in vitro and in vivo evaluation and molecular docking study of novel pleuromutilin derivatives as antibacterial agents.
Liu J; Ren J; Zuo XY; Zhou KX; Tang YZ; Jin Z
Fitoterapia; 2024 Jul; 176():106046. PubMed ID: 38821322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
